Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy

Ítems similars

• Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy
  per: Crittenden, Marka R., et al.
  Publicat: (2012)
• Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
  per: Young, Kristina H., et al.
  Publicat: (2016)
• The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor.
  per: Marka R Crittenden, et al.
  Publicat: (2013-01-01)
• The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor
  per: Crittenden, Marka R., et al.
  Publicat: (2013)
• Phase I/II clinical trial of anti-OX40, radiation and cyclophosphamide in patients with prostate cancer: immunological analysis
  per: Kovacsovics-Bankowski, Magdalena, et al.
  Publicat: (2013)